Howard Fine, M.D., Chief, NCI Neuro-Oncology Branch, discusses how the The Cancer Genome Atlas data may be used to understand cancer stem cells and how they may differ in different cancers. He talks about the need to test the hypothesis that these cancer stem cells will be better for screening new treatments for various types of cancer.
Information on The Nation's Investment in Cancer Research: http://www.cancer.gov/aboutnci/budget_planning_leg/plan-2012/cancerbiology?ci...
Link to this comment:
All Comments (0)